For a long time d(10)-ML2 fragments have been known for their potential to activate unreactive bonds by oxidative addition. In the development of more active species, two approaches have proven successful: the use of strong σ-donating ligands leading to electron-rich metal centers and the employment of chelating ligands resulting in a bent coordination geometry. Combining these two strategies, we synthesized bis-NHC chelate complexes of nickel(0) and platinum(0). Bis(1,5-cyclooctadiene)nickel(0) and -platinum(0) react with bisimidazolium salts, deprotonated in situ at room temperature, to yield tetrahedral or trigonal-planar bis-NHC chelate olefin complexes. The synthesis and characterization of these complexes as well as a first example of C-C bond activation with these systems are reported. Due to the enforced cis arrangement of two NHCs, these compounds should open interesting perspectives for bond-activation chemistry and catalysis.
Platinum(II) cis-dimethyl and cis-dineopentyl complexes bearing the alkyl-substituted bis-NHC ligands L t-Bu , L Me , and L i-Pr (L t-Bu = 1,1′-di-tert-butyl-3,3′-methylenediimidazolin-2,2′-diylidene, L Me = 1,1′-dimethyl-3,3′-methylenediimidazolin-2,2′-diylidene, L i-Pr = 1,1′-diisopropyl-3,3′methylenediimidazolin-2,2′-diylidene) as well as novel cisalkyl chloro and cis-alkyl hydrido compounds were synthesized. The reactivity of the dimethyl complexes toward dichloromethane and methanol was investigated. Reductive elimination of alkanes from cis-alkyl hydrido complexes requires much higher temperatures than in related bisphosphine systems, which limits their applicability for the generation of reactive, bent platinum(0) d 10 -ML 2 fragments for bond-activation chemistry. The platinum(II) complexes were characterized by NMR and IR spectroscopy, mass spectrometry, elemental analysis, and X-ray diffraction in most cases.
The
employment of lithium hexamethyldisilazide for the deprotonation
of methylene-bridged bis(imidazolium) salts led to the formation of
lithium carbene adducts. Depending on the crystallization method and
the substituents of the ligands, monomeric, dimeric, or polymeric
solid-state structures were obtained. These lithium carbene complexes
represent the first examples of lithium complexes bearing neutral
bis(N-heterocyclic carbene) ligands.
A direct one-pot
copper-catalyzed oxidative C–C bond cleavage
route to the synthesis of pyridoquinazolinones is described. This
one-pot strategy involves a copper-catalyzed C–N coupling followed
by concomitant C(sp3)–H oxidation and amidation via oxidative C–C bond cleavage under an O2 atmosphere to deliver the target molecules in high yields.
d 10 -ML 2 -Fragmente sind seit langem für ihr Potenzial bekannt, unreaktive Bindungen durch oxidative Addition zu aktivieren. Bei der Entwicklung aktiverer Spezies haben sich zwei Ansätze bewährt: Der Einsatz von starken s-Donorliganden, die zu elektronenreichen Metallzentren führen, sowie von Chelatliganden, die eine gewinkelte Koordinationsgeometrie erzeugen. Wir haben beide Strategien kombiniert und Nickel(0)-sowie erstmals Platin(0)-Bis-NHC-Chelatkomplexe synthetisiert. Bis(1,5-Cyclooctadien)nickel(0) und -platin(0) reagieren mit in situ deprotonierten Bisimidazoliumsalzen bei Raumtemperatur zu tetraedrischen oder trigonal-planaren Bis-NHC-Chelat-Olefinkomplexen. Die Synthese und Charakterisierung dieser Komplexe sowie ein erstes Beispiel einer C-C-Bindungsaktivierung mit diesen Systemen werden beschrieben. Wegen der erzwungenen cis-Anordnung zweier NHCs erçffnen diese Verbindungen interessante Perspektiven für Bindungsaktivierungen und Katalyse. Schema 1. Bisphosphanplatin(0)-Systeme, die Bindungsaktivierungen ermçglichen (R = Me, Et; Cy = Cyclohexyl).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.